Location: New York, NY
CIK: 0001931118 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value: $79.33M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | 187,633 | $10.17M | 12.8% | $51.15 | +18.0% | COM NEW | 23282W605 |
| LEGN | LEGEND BIOTECH CORP | 154,665 | $6.85M | 8.6% | $44.29 | — | SPONSORED ADS | 52490G102 |
| TERN | TERNS PHARMACEUTICALS INC | 956,542 | $6.514M | 8.2% | $6.06 | 0.0% | COM | 880881107 |
| BBIO | BRIDGEBIO PHARMA INC | 219,837 | $5.568M | 7.0% | $31.69 | -13.7% | COM | 10806X102 |
| — | 89BIO INC | 680,403 | $5.45M | 6.9% | $11.17 | — | COM | 282559103 |
| NKTX | NKARTA INC | 875,999 | $5.177M | 6.5% | $8.12 | -12.8% | COM | 65487U108 |
| ZLAB | ZAI LAB LTD | 215,178 | $3.729M | 4.7% | $17.33 | — | ADR | 98887Q104 |
| KROS | KEROS THERAPEUTICS INC | 74,288 | $3.395M | 4.3% | $43.54 | +23.4% | COM | 492327101 |
| ACLX | ARCELLX INC | 59,133 | $3.264M | 4.1% | $54.36 | 0.0% | COMMON STOCK | 03940C100 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 111,133 | $2.888M | 3.6% | $24.57 | 0.0% | COM | 04280A100 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 56,468 | $2.555M | 3.2% | $42.06 | 0.0% | COM NEW | 21833P301 |
| ONC | BEIGENE LTD | 12,508 | $1.785M | 2.2% | $142.67 | — | SPONSORED ADR | 07725L102 |
| FATE | FATE THERAPEUTICS INC | 497,360 | $1.631M | 2.1% | $2.66 | +64.4% | COM | 31189P102 |
| ALLO | ALLOGENE THERAPEUTICS INC | 689,912 | $1.607M | 2.0% | $3.44 | -14.3% | COM | 019770106 |
| PYXS | PYXIS ONCOLOGY INC | 484,443 | $1.604M | 2.0% | $4.21 | -0.0% | COMMON STOCK | 747324101 |
| APGE | APOGEE THERAPEUTICS INC | 36,928 | $1.453M | 1.8% | $43.66 | +11.2% | COM | 03770N101 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,151,518 | $1.405M | 1.8% | $1.91 | +4.5% | COM | 23284F105 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 64,213 | $1.234M | 1.6% | $20.06 | 0.0% | ORDINARY SHARES | N62509109 |
| — | TOURMALINE BIO INC | 95,229 | $1.225M | 1.5% | $20.24 | — | COM | 89157D105 |
| NVCR | NOVOCURE LTD | 66,892 | $1.146M | 1.4% | $17.59 | 0.0% | ORD SHS | G6674U108 |
| SYRE | SPYRE THERAPEUTICS INC | 45,571 | $1.071M | 1.4% | $33.73 | 0.0% | COM NEW | 00773J202 |
| CABA | CABALETTA BIO INC | 139,895 | $1.046M | 1.3% | $21.46 | -42.9% | COM | 12674W109 |
| TNGX | TANGO THERAPEUTICS INC | 115,571 | $992K | 1.2% | $7.73 | 0.0% | COM | 87583X109 |
| — | ALLAKOS INC | 940,578 | $941K | 1.2% | $1.26 | — | COM | 01671P100 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 87,638 | $874K | 1.1% | $14.46 | 0.0% | COM NEW | 46489V302 |
| SVRA | SAVARA INC | 200,000 | $806K | 1.0% | $4.44 | +0.3% | COM | 805111101 |
| BMEA | BIOMEA FUSION INC | 167,110 | $752K | 0.9% | $10.16 | 0.0% | COM | 09077A106 |
| KURA | KURA ONCOLOGY INC | 36,242 | $746K | 0.9% | $20.56 | 0.0% | COM | 50127T109 |
| ZURA | ZURA BIO LTD | 156,626 | $548K | 0.7% | $4.08 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| ATYR | ATYR PHARMA INC | 313,028 | $488K | 0.6% | $1.74 | 0.0% | COM NEW | 002120202 |
| PEPG | PEPGEN INC | 29,249 | $467K | 0.6% | $11.81 | +21.4% | COM | 713317105 |
| — | KARYOPHARM THERAPEUTICS INC | 534,485 | $464K | 0.6% | $0.87 | — | COM | 48576U106 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 37,838 | $329K | 0.4% | $13.97 | 0.0% | COM NEW | 30233G209 |
| — | MARINUS PHARMACEUTICALS INC | 261,861 | $306K | 0.4% | $10.54 | — | COM NEW | 56854Q200 |
| — | MERSANA THERAPEUTICS INC | 110,073 | $221K | 0.3% | $2.01 | — | COM | 59045L106 |
| — | LAKESHORE BIOPHARMA CO LTD | 307,920 | $200K | 0.3% | $0.54 | — | ORDINARY SHARES | G9845F109 |
| CMPS | COMPASS PATHWAYS PLC | 32,497 | $196K | 0.2% | $6.04 | — | SPONSORED ADS | 20451W101 |
| SYRS | SYROS PHARMACEUTICALS INC | 37,789 | $195K | 0.2% | $5.25 | 0.0% | COM NEW | 87184Q206 |
| — | SPRUCE BIOSCIENCES INC | 77,992 | $40,376 | 0.1% | $1.36 | — | COM | 85209E109 |